[144] Dorman Products, Inc. SEC Filing

Rhea-AI Filing Summary

Dorman Products (DORM) filing a Form 144 notifies the proposed sale of 144,000 common shares through Merrill Lynch, with an aggregate market value of $22,896,000 and approximate sale date of 09/16/2025 on NASDAQ. The filer reports these shares were originally acquired as founder stock on 01/29/1987 in exchange for an ownership interest, with payment characterized as equity. The filing also discloses a prior sale of 144,000 shares on 06/17/2025 for $19,923,096. The issuer's reported number of shares outstanding is 30,534,243. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

• None.

Negative

• Planned sale of 144,000 common shares with an aggregate market value of $22,896,000, which could increase share supply.
• Prior sale of 144,000 shares on 06/17/2025 for $19,923,096, indicating recent insider liquidity activity.

Insights

Financial Analyst

TL;DR: Insider plans to sell a sizable block of 144,000 shares, previously partially sold in June; routine disclosure but notable scale.

The Form 144 indicates a proposed sale of 144,000 common shares via Merrill Lynch with an aggregate market value of $22,896,000 and a prior sale of the same quantity on 06/17/2025 for $19,923,096. For an analyst, the material facts are the quantity, stated value, and that these shares were founder stock acquired in 1987 and characterized as equity consideration. This is a compliance-driven disclosure under Rule 144; it notifies the market of potential incremental supply from an insider. No earnings, liabilities, or forward-looking guidance are provided in this filing.

Corporate Governance Expert

TL;DR: The filing is a standard insider sale notice; it provides required transparency but does not by itself indicate governance issues.

The document documents a planned disposition of founder-acquired shares and a recent prior sale by the same trust. It affirms the seller's representation about public disclosure of material information and cites Rule 10b5-1 language. From a governance perspective, the filing meets disclosure requirements and provides investors with transactional detail—share counts, values, acquisition history, and broker—allowing stakeholders to monitor insider liquidity. The filing contains no allegations, litigation, or management changes.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	MERRILL LYNCH 470 NORRISTOWN RD BLUE BELL PA 19422	144000	22896000	30534243	09/16/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	01/29/1987	PAYMENT OF FOUNDER STOCK IN EXCHANGE FOR OWNERSHIP INTEREST IN PARTNERSHIP	BREP INC, JORDAN BERMAN, RICHARD BERMAN, STEVEN BERMAN, FRED BERMAN, MARC BERMAN			144000	01/29/1987	EQUITY

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
R BERMAN 2009 TRUST PO BOX 554 GWYNEDD VALLEY PA 19437	COMMON	06/17/2025	144000	19923096

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for DORM disclose?

The filing discloses a proposed sale of 144,000 common shares through Merrill Lynch with an aggregate market value of $22,896,000 and an approximate sale date of 09/16/2025.

Who acquired the shares and when were they acquired?

The shares were acquired as founder stock on 01/29/1987 in exchange for an ownership interest; payment is characterized as equity.

Has the filer sold any shares recently?

Yes, the filing reports a prior sale of 144,000 common shares on 06/17/2025 for gross proceeds of $19,923,096.

Through which broker will the proposed sale be executed?

The proposed sale is to be executed through Merrill Lynch, 470 Norristown Rd, Blue Bell, PA 19422.

How many shares does the issuer report outstanding?

The filing reports 30,534,243 shares outstanding for the issuer.